iShares Core MSCI Emerging Markets ETF (IEMG)

NYSEArca Currently down 0.01 (-0.01%) in today's trading session

2 members of Congress have disclosed 10 trades in iShares Core MSCI Emerging Markets ETF (IEMG) via STOCK Act filings. The most recent disclosure was a purchase by John Curtis on 30 December 2022. The most active traders have been John Curtis (6) and Mikie Sherrill (4). Aggregate disclosed activity totals roughly $190K in purchases and $24K in sales (midpoint estimates from bracketed disclosure amounts).

iShares Core MSCI Emerging Markets ETF is currently trading at $80.57, positioned at 90% of its 52-week range ($56.38 – $83.29).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Free asset at sign up • Eligible regions only
Live portfolio tracking
Automatic rebalancing

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Not available in the US.

Past Performance is not an indication of future results.

*Free asset promotion available at sign up in eligible regions only. Terms and conditions apply.

Current Price
$80.57
24h Change
-0.01 (-0.01%)
52 Week Range
$56.38$83.29
View on NASDAQ

iShares Core MSCI Emerging Markets ETF Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for IEMG

Select to highlight on chart
0 transactions
Compliance: 0%
No data

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$150.97B

Volume

10.42M

Beta

0.99

P/E Ratio

17.94

Fundamentals

EPS

$4.49

Div. Yield

2.29%

Open

$80.73

Day Range

$80.40 — $81.19

Company Information

Sector
Financial Services
Industry
Asset Management
Exchange
AMEX · USD
Country
US
IPO Date
2012-10-24

The iShares Core MSCI Emerging Markets ETF seeks to track the investment results of an index composed of large-, mid- and small-capitalization emerging market equities.

No earnings data available for this stock.

Dividends

Dividend History

16 Dec 2025
Amount $1.1389
16 Jun 2025
Amount $0.7097
17 Dec 2024
Amount $1.1625
11 Jun 2024
Amount $0.5095
20 Dec 2023
Amount $0.9770
7 Jun 2023
Amount $0.4832
13 Dec 2022
Amount $0.6589
9 Jun 2022
Amount $0.6044
13 Dec 2021
Amount $1.3613
10 Jun 2021
Amount $0.4705
14 Dec 2020
Amount $0.7235
15 Jun 2020
Amount $0.4364
16 Dec 2019
Amount $1.2012
17 Jun 2019
Amount $0.4914
18 Dec 2018
Amount $0.8586
19 Jun 2018
Amount $0.4419
19 Dec 2017
Amount $0.9735
20 Jun 2017
Amount $0.3609
21 Dec 2016
Amount $0.5856
22 Jun 2016
Amount $0.3808
21 Dec 2015
Amount $0.5463
25 Jun 2015
Amount $0.4485
17 Dec 2014
Amount $0.6392
25 Jun 2014
Amount $0.4441
18 Dec 2013
Amount $0.4614
27 Jun 2013
Amount $0.4163
27 Dec 2012
Amount $0.0083
18 Dec 2012
Amount $0.1122

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations

Frequently Asked Questions about IEMG

Which members of Congress have traded IEMG?
2 members of Congress have disclosed 10 trades in iShares Core MSCI Emerging Markets ETF (IEMG) under the STOCK Act. The most active traders are John Curtis and Mikie Sherrill.
When was IEMG most recently disclosed by Congress?
The most recent IEMG disclosure was a purchase by John Curtis on 30 December 2022.
What is the total disclosed congressional trading volume for IEMG?
Members of Congress have disclosed approximately $190K in IEMG purchases and $24K in sales. These figures are midpoint estimates derived from the bracketed amount ranges used in STOCK Act filings.
How can I track new congressional trades in IEMG?
This IEMG page updates as soon as new STOCK Act disclosures are filed for iShares Core MSCI Emerging Markets ETF. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
© 2026 - All rights reserved. Powered by Vantara Labs
This website is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office, or her representatives. Any use of her name is solely for the purpose of discussing publicly available information.The information provided on this website is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.